[II International congress on the strategy of symptomatic treatment in oncology].
Azab
M
M
Institut Gustave-Roussy, Villejuif, France.
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001685:Biological Factors / Q000502:physiology; D006801:Humans; D007239:Infections / Q000188:drug therapy / Q000209:etiology; D008659:Metabolic Diseases / Q000209:etiology*; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*; D009503:Neutropenia / Q000150:complications; D010148:Intractable Pain / Q000188:drug therapy; D010166:Palliative Care; D014839:Vomiting / Q000188:drug therapy / Q000209:etiology
D000932:Antiemetics; D000970:Antineoplastic Agents; D001685:Biological Factors
IIe congrès international de stratégie de traitement symptomatique en oncologie.